Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
Go back to Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer| Oppenheimer Rising Dividends Fund, Inc. Class A (NASDAQ: ARDX) | Delayed: 3.89 -0.01 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.90 | 52 Week High | $20.98 | |||
| Open | $3.92 | 52 Week Low | $6.36 | |||
| Day High | $3.97 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $0.00 | |||
| Volume | 2,878,986 | |||||
